Mon. May 25th, 2026
Spread the love

French President Emmanuel Macron is said to be deeply frustrated with Nigerian President Bola Tinubu over the botched sale of TotalEnergies’ 10% stake in the SPDC onshore joint venture, according to multiple sources, who briefed Huhuonline.com, on conditions of anonymity. The deal, intended to free TotalEnergies from Nigeria’s high-risk onshore oil sector and allow a pivot into deepwater and gas, has stalled. The buyer, Chappal Energies, has reportedly failed to raise the funds, and internal conflicts and reputational damage are mounting for TotalEnergies.

 

NNPC sources told Huhuonline.com that the collapse of this transaction, valued at about US$860 million, is not simply a commercial failure. It is being seen in French diplomatic circles as a betrayal of trust, a signal that Nigeria under Tinubu is becoming an unreliable partner in energy deals. Industries close to Macron are increasingly worried that Nigeria’s regulatory, political, and infrastructural unpredictability is making French investment riskier.

 

What Went Wrong

An oil industry expert who spoke to Huhuonline.com on conditions of anonymity because he was not authorized to comment on the issue, disclosed that TotalEnergies structured the deal to sell its 10% stake in SPDC onshore licenses to Chappal Energies, which had past experience with distressed assets and had recently executed a sizeable deal with Equinor. However, Chappal has apparently been unable to finalize financing, in part because TotalEnergies’ valuation was seen as too high compared to similar transactions (ex, Shell’s earlier divestment of a 30% SPDC stake). Operational risk in the Niger Delta – sabotage, oil theft, environmental liabilities – have only magnified concerns, the source noted. The delay has triggered internal tensions at TotalEnergies headquarters, with executives being blamed for selecting a buyer poorly equipped to complete the deal, and for misjudging the political risk in onshore Nigerian operations. 

 

Macron’s displeasure reportedly stems from several dimensions, not the least of which is the loss of what one source described as “strategic credibility.” France has long touted its multi-national companies as responsible investors in Africa, combining commercial strength with environmental, social, and governance (ESG) obligations. Such a high-profile failure undermines those claims. Besides, energy deals are central tools of economic diplomacy. When they falter, especially in politically sensitive sectors like oil, they weaken trust between states. Macron likely views this as a breach of expected standards – regulatory cooperation, transparency, reliable partners.

 

Back home in France, TotalEnergies is under pressure from investors and regulators to deliver on its pivot to cleaner energy and higher-margin ventures. Delays in Nigerian deals feed into criticism that the company is not executing its strategy, which reflects poorly on France’s energy diplomacy. Most importantly is geopolitical signaling. In a tighter global energy market, where senior executives and governments weigh risk heavily, failed transactions send signals. Other French companies may think twice before making large commitments in Nigeria, especially in sectors with high environmental, security, or regulatory risk.

 

One Aso Rock source noted that the implications for Nigeria-France relations is dire. If things do not move quickly to repair this fissure, the source warned, investor confidence could wane. French firms may increasingly view Nigeria as a difficult place to do business – unpredictable contract enforcement, political risk, regulatory delays. This could slow or reduce future French investment, not just in energy, but across infrastructure, technology, and other strategic sectors. This could strain diplomatic relations because Macron will have to answer questions at home: why did French state-backed companies expose themselves to this risk? Was enough due diligence done? Bilateral relations may suffer unless Nigeria takes visible steps to ensure transparency, regulatory stability, and contract certainty.

 

To which end, Nigeria may find itself under pressure – diplomatic, legal, or from multilateral institutions – to reform its systems: upstream licensing, environmental regulation, enforcement against oil theft and sabotage, financial regulatory certainty. Failure could not only cost Nigeria economically but also reputationally in forums such as Africa-EU or climate-related negotiations. France may shift away from onshore oil deals and lean more heavily into gas, offshore, or alternative energy projects in Nigeria (or elsewhere in Africa) with lower risk profiles. Bilateral cooperation may tilt more toward energy transition, renewables, green infrastructure, and away from troubled onshore oil projects.

 

What Nigeria must do is to urgently release the full details of the transaction, deadlines, and what went wrong in Chappal’s financing. Nigeria must also commit to predictable approvals, clear environmental standards, and security assurances. In addition, Nigeria should demonstrate that other French-led or French-backed projects are on schedule and fulfilling obligations. Finally, senior Nigerian and TotalEnergies stakeholders must publicly engage with French counterparts to salvage confidence.

 

Bottom Line

France’s patience may be wearing thin. The TotalEnergies SPDC sale fiasco is more than a business glitch; it is a diplomatic sore point exposing cracks in Nigeria’s ability to be a reliable partner. Macron is angry. For Tinubu, the path forward demands immediate, visible acts of healing: transparency, regulatory reform, contract integrity. Without that, Nigeria risks not just losing investments, but seeing its standing with one of its most important international partners erode.

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.